Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 1 January 2023 5 April 2024 5 April 2024 14487811 Mr William McClatchie iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14487811 2022-12-31 14487811 2024-04-05 14487811 2023-01-01 2024-04-05 14487811 frs-core:CurrentFinancialInstruments 2024-04-05 14487811 frs-bus:PrivateLimitedCompanyLtd 2023-01-01 2024-04-05 14487811 frs-bus:FilletedAccounts 2023-01-01 2024-04-05 14487811 frs-bus:Micro-entities 2023-01-01 2024-04-05 14487811 frs-bus:AuditExempt-NoAccountantsReport 2023-01-01 2024-04-05 14487811 frs-bus:Director1 2023-01-01 2024-04-05
Registered number: 14487811
Coxagen Limited
Unaudited Financial Statements
For the Period 1 January 2023 to 5 April 2024
Sharpe Medical Accounting Ltd
Balance Sheet
Registered number: 14487811
5 April 2024
£
Fixed assets 10,000
Current assets 16,533
Prepayments and accrued income 312
Creditors: Amounts Falling Due Within One Year (6,581 )
NET CURRENT ASSETS 10,264
TOTAL ASSETS LESS CURRENT LIABILITIES 20,264
Accruals and deferred income (1,200 )
NET ASSETS 19,064
CAPITAL AND RESERVES 19,064

Notes

1. General Information
Coxagen Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14487811 . The registered office is C/O Sharpe Medical Accounting Limited, Normanby Gateway, Lysaghts Way, Scunthorpe, North Lincolnshire, DN15 9YG.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
Page 0
Page 1
For the period ending 5 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr William McClatchie
Director
24/09/2024